Cargando…

An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

BACKGROUND: Ending the global tuberculosis (TB) epidemic requires a focus on treating individuals with latent TB infection (LTBI) to prevent future cases. Promising trials of shorter regimens have shown them to be effective as preventative TB treatment, however there is a paucity of data on self-adm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surey, J., Stagg, H. R., Yates, T. A., Lipman, M., White, P. J., Charlett, A., Muñoz, L., Gosce, L., Rangaka, M. X., Francis, M., Hack, V., Kunst, H., Abubakar, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818935/ https://www.ncbi.nlm.nih.gov/pubmed/33478428 http://dx.doi.org/10.1186/s12879-021-05766-9

Ejemplares similares

Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study
por: Heyd, Amber, et al.
Publicado: (2021)

939 Electronic Mail (email) Reminders as an Alternative to Directly Observed Therapy (DOT) for the Treatment of Latent Tuberculosis Infection (LTBI) using 12 weeks of Rifapentine and INH (R plus I) for Healthcare Workers (HCWs)
por: Lacaille, Sherard N.J., et al.
Publicado: (2014)

Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug
por: Svensson, Elin M., et al.
Publicado: (2015)

Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland
por: von Both, Ulrich, et al.
Publicado: (2021)

Prevalence of Latent Tuberculosis Infection (LTBI) in Mexican Patients With Rheumatoid Arthritis (RA)
por: Zavala del Ángel, Abel Eduardo, et al.
Publicado: (2023)

Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection
por: Holland, David P., et al.
Publicado: (2011)

Prevalence of latent tuberculosis infection among participants of the national LTBI screening program in South Korea – A problem of low coverage rate with current LTBI strategy
por: Kim, Hyung Woo, et al.
Publicado: (2023)

Risk factors for latent tuberculosis infection (LTBI) in health profession’s students of the University of Parma
por: Bonini, Silvia, et al.
Publicado: (2017)

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
por: Borisov, Andrey S., et al.
Publicado: (2018)

1692 Do Resident Physicians Agree with LTBI Treatment Guidelines?
por: Janakiraman, Arun, et al.
Publicado: (2014)

Comparison of IFN-γ Levels in Children with Tuberculosis Disease (TB) and Latent Tuberculosis Infection (LTBI)
por: Boskovska, Katerina, et al.
Publicado: (2018)

Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention
por: Stagg, Helen R., et al.
Publicado: (2019)

Impact of Age on Outcome of Rifapentine-Based Weekly Therapy for Latent Tuberculosis Infection
por: Huang, Hung-Ling, et al.
Publicado: (2020)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
por: Ilaiwy, Ghassan, et al.
Publicado: (2021)

Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study
por: Kloprogge, Frank, et al.
Publicado: (2021)

753. Screening for Latent Mycobacterium tuberculosis Infection (LTBI): A Clinical Conundrum of Public Health Concern
por: Bricker, Lauren, et al.
Publicado: (2018)

The Prevalence and Demographic Risk Factors for Latent Tuberculosis Infection (LTBI) Among Healthcare Workers in Semarang, Indonesia
por: Erawati, Meira, et al.
Publicado: (2020)

938 Identification of High Risk Healthcare Workers with Latent Tuberculosis Infection (LTBI) in an Inner City Healthcare System
por: Dhar, Sorabh, et al.
Publicado: (2014)

Prevalence and Risk Factors of Latent Tuberculosis Infection (LTBI) in Patients with Type 2 Diabetes Mellitus (T2DM)
por: Ping, Phan Ai, et al.
Publicado: (2021)

The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB)
por: Zellweger, Jean-Pierre, et al.
Publicado: (2020)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

Safety & Benefits of Directly Observed Therapy with Rifapentine and Isoniazid for Latent Tuberculosis Infection – Less is More?
por: Ha, Lawrence, et al.
Publicado: (2017)

Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial
por: Burman, M., et al.
Publicado: (2019)

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment
por: Yoopetch, Panida, et al.
Publicado: (2022)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness
por: Nwana, Nwabunie, et al.
Publicado: (2019)

1869. Knowledge about and Perceptions of Latent Tuberculosis Infection (LTBI) among Physicians and Advanced Practice Providers at Tufts Medical Center
por: Boomsma, Cassidy, et al.
Publicado: (2023)

Peer Support Workers in Health: A Qualitative Metasynthesis of Their Experiences
por: MacLellan, Jennifer, et al.
Publicado: (2015)

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
por: Abubakar, Ibrahim, et al.
Publicado: (2020)

Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?
por: Zheng, Chunlan, et al.
Publicado: (2017)

1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT)
por: Kusztos, Amanda E, et al.
Publicado: (2018)

Multi-Level Barriers to LTBI Treatment: A Research Note
por: Hill, Linda, et al.
Publicado: (2008)

Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice
por: Umeda, Tomohiro, et al.
Publicado: (2022)

Rifapentine-Proliposomes for Inhalation: In Vitro and In Vivo Toxicity
por: Patil-Gadhe, Arpana A., et al.
Publicado: (2014)

Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention
por: Podany, Anthony T.
Publicado: (2020)

Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses
por: Pease, Christopher, et al.
Publicado: (2017)

Working conditions and tuberculosis mortality in England and Wales, 1890–1912: a retrospective analysis of routinely collected data
por: Jackson, Charlotte, et al.
Publicado: (2016)

Using peer advocates to improve access to services among hard-to-reach populations with hepatitis C: a qualitative study of client and provider relationships
por: MacLellan, Jennifer, et al.
Publicado: (2017)

Integrated Care for Latent Tuberculosis Infection (LTBI) at a Primary Health Care Facility for Refugees in Winnipeg, Canada: A Mixed-Methods Evaluation
por: Benjumea-Bedoya, Dione, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ea61nlq4h9a3fcgc2dn6vnhe22